http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2016505-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6dacaa0ceae8e4330441f7bb1f70cb0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G69-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G69-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G69-10
filingDate 1990-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2001-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58ff5ff16fdfc6160d536b3586f0d562
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ca7e10385583172794e8b97e111e694
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c13a19760a1079f8f258eaeedab3571
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b563a405ce37b76a1472245d7ac0290
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73918d0b0812606a28fe4dbeb31a128c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53dd40e320afab5e0496955362d74456
publicationDate 2001-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2016505-C
titleOfInvention Water soluble high molecular polymerized drug preparation
abstract This invention is a water-soluble high molecular polymerized drug comprising a water-soluble block copolymer consisting of a hydrophilic segment and a hydrophobic pharmacological-functioning segment to side chain of which a drug is bonded. The hydrophilic first segment of the present invention include polyethylene glycol, polysaccharides, polyacrylamide, and so on. The hydrophobic segment being attached to a drug include polyaspartic acid, polyglutamic acid, polylysine, or derivatives thereof. Drugs to be attached to the hydrophobic segment include anti-cancer drugs, drugs for central nerve, drugs for peripheral nerve, drugs for circulatory organs, and so on.
priorityDate 1989-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539584
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5960
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID289672
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID289672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703

Total number of triples: 37.